Literature DB >> 15452222

Anti-Vpr activity of a yeast chaperone protein.

Zsigmond Benko1, Dong Liang, Emmanuel Agbottah, Jason Hou, Karen Chiu, Min Yu, Scott Innis, Patrick Reed, William Kabat, Robert T Elder, Paola Di Marzio, Lorena Taricani, Lee Ratner, Paul G Young, Michael Bukrinsky, Richard Yuqi Zhao.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) exerts multiple effects on viral and host cellular activities during viral infection, including nuclear transport of the proviral integration complex, induction of cell cycle G(2) arrest, and cell death. In this report, we show that a fission yeast chaperone protein Hsp16 inhibits HIV-1 by suppressing these Vpr activities. This protein was identified through three independent genome-wide screens for multicopy suppressors of each of the three Vpr activities. Consistent with the properties of a heat shock protein, heat shock-induced elevation or overproduction of Hsp16 suppressed Vpr activities through direct protein-protein interaction. Even though Hsp16 shows a stronger suppressive effect on Vpr in fission yeast than in mammalian cells, similar effects were also observed in human cells when fission yeast hsp16 was expressed either in vpr-expressing cells or during HIV-1 infection, indicating a possible highly conserved Vpr suppressing activity. Furthermore, stable expression of hsp16 prior to HIV-1 infection inhibits viral replication in a Vpr-dependent manner. Together, these data suggest that Hsp16 inhibits HIV-1 by suppressing Vpr-specific activities. This finding could potentially provide a new approach to studying the contribution of Vpr to viral pathogenesis and to reducing Vpr-mediated detrimental effects in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452222      PMCID: PMC521794          DOI: 10.1128/JVI.78.20.11016-11029.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.

Authors:  L J Chang; V Urlacher; T Iwakuma; Y Cui; J Zucali
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

2.  Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.

Authors:  J S Gibbs; D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1994-04       Impact factor: 2.205

3.  Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.

Authors:  S Gummuluru; M Emerman
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.

Authors:  L D Shostak; J Ludlow; J Fisk; S Pursell; B J Rimel; D Nguyen; J D Rosenblatt; V Planelles
Journal:  Exp Cell Res       Date:  1999-08-25       Impact factor: 3.905

5.  Induction of cell differentiation by human immunodeficiency virus 1 vpr.

Authors:  D N Levy; L S Fernandes; W V Williams; D B Weiner
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

6.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

Authors:  N K Heinzinger; M I Bukrinsky; S A Haggerty; A M Ragland; V Kewalramani; M A Lee; H E Gendelman; L Ratner; M Stevenson; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  Heterodimerization of the Drosophila ecdysone receptor with retinoid X receptor and ultraspiracle.

Authors:  H E Thomas; H G Stunnenberg; A F Stewart
Journal:  Nature       Date:  1993-04-01       Impact factor: 49.962

Review 8.  Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.

Authors:  D R Ciocca; S Oesterreich; G C Chamness; W L McGuire; S A Fuqua
Journal:  J Natl Cancer Inst       Date:  1993-10-06       Impact factor: 13.506

9.  Thiamine-repressible expression vectors pREP and pRIP for fission yeast.

Authors:  K Maundrell
Journal:  Gene       Date:  1993-01-15       Impact factor: 3.688

Review 10.  Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection.

Authors:  B G Brenner; M A Wainberg
Journal:  Infect Dis Obstet Gynecol       Date:  1999
View more
  14 in total

1.  The dose-dependent H2O2 stress response promotes increased survival for Schizosaccharomyces pombe cells expressing HIV-1 Vpr.

Authors:  J Antal; M Pesti
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 2.  Vpr-host interactions during HIV-1 viral life cycle.

Authors:  Richard Y Zhao; Ge Li; Michael I Bukrinsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-12       Impact factor: 4.147

3.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

4.  HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.

Authors:  Ge Li; Robert T Elder; Larisa Dubrovsky; Dong Liang; Tatiana Pushkarsky; Karen Chiu; Tao Fan; Josephine Sire; Michael Bukrinsky; Richard Y Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

5.  Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Authors:  Ge Li; Hyeon U Park; Dong Liang; Richard Y Zhao
Journal:  Retrovirology       Date:  2010-07-07       Impact factor: 4.602

Review 6.  HIV-1 viral protein R (Vpr) and its interactions with host cell.

Authors:  Ge Li; Michael Bukrinsky; Richard Y Zhao
Journal:  Curr HIV Res       Date:  2009-03       Impact factor: 1.581

7.  Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Authors:  Sylvain Huard; Robert T Elder; Dong Liang; Ge Li; Richard Y Zhao
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

8.  Anti-vpr activities of heat shock protein 27.

Authors:  Dong Liang; Zsigmond Benko; Emmanuel Agbottah; Michael Bukrinsky; Richard Y Zhao
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 9.  Contribution of yeast models to virus research.

Authors:  R Sahaya Glingston; Jyoti Yadav; Jitika Rajpoot; Neha Joshi; Shirisha Nagotu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.813

10.  Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe).

Authors:  Zsigmond Benko; Dong Liang; Emmanuel Agbottah; Jason Hou; Lorena Taricani; Paul G Young; Michael Bukrinsky; Richard Y Zhao
Journal:  Retrovirology       Date:  2007-03-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.